Treatment of Overweight in General Practice

Sponsor
University of Oslo (Other)
Overall Status
Completed
CT.gov ID
NCT03000062
Collaborator
(none)
23
2
35

Study Details

Study Description

Brief Summary

In this study the investigators want to explore the feasibility and effect of a simple intervention provided by primary care physicians on treatment for overweight in general practice. Regular patients visiting their ordinary family physician will be asked for participation if they comply with the inclusion criteria. If so, they will follow a detailed food list for 12 months with regular visits to the doctor. At each visit, the participating patients will be asked about their progress on weight loss and all measurements will be made. Simultaneously a control group of primary care physicians will also recruit patients that fulfill the inclusion criteria. These patients will also provide data that will serve as Control to the intervention group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Intervention group
N/A

Detailed Description

The number of patients with overweight is increasing and a daily issue in general practice. Many patients wish to discuss their weight problem with their family physician but many of these feel helpless to guide their patients in how to reduce weight. Providing useful and correct information should not be so difficult but many doctors choose to refer their patients to dietary courses or follow-up in specialist health care.In this study the investigators wish to implement a simple tool for treatment of overweight in primary care by providing the patients a detailed list for all meals that will ensure a weight loss. The patients will be given a close follow-up by their doctor, and the motivating conversation and list of meals will be the only treatment given.

The study is a cluster randomised controlled trial where all general practices in the area of Moss city in Norway will be asked to participate. Half of the physicians will constitute the intervention group while the other half will serve as control group. Each participating doctor in both groups will recruit patients according to the eligibility criteria. The doctors in the intervention group will be provided with a course to learn the intervention and have a manual to follow for each patient. All participating patients of both groups will be asked to meet regularly for data collection.

According to the power calculation, a number of 12 physicians in each group will be sufficient if they recruit 10 patients each.

The intervention will be conducted for 12 months and thereafter data will be continued to be collected at 6 and 12 months after.

Study Design

Study Type:
Interventional
Actual Enrollment :
23 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Cluster randomized controlled trialCluster randomized controlled trial
Masking:
Single (Participant)
Masking Description:
ID of participating patients are only available through the participating Family phyisican
Primary Purpose:
Treatment
Official Title:
Treatment of Overweight in General Practice
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Dec 1, 2018
Actual Study Completion Date :
Dec 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

12 Family physicians in primary care will constitute the Intervention group. They will enroll 10 patients each from their ordinary practice. The physicians will be provided with a specific course on the treatment model of the study, including how to collect and register data. They will have a detailed manual indicating the content of each visit. Following recruitment and consent, the patient will meet for the first visit in the study one week later. At this visit the patient will be provided with detailed information on the content and preparation for all meals. Data will be collected. The manual describes a diet in accordance with official guidelines providing the patient 1600Kcal per day. The following visits will take place after 4 weeks, 8 weeks, 4 months, 8 months and 12 months from the first visit. Data will be collected at all visits, and also at 6 and 12 months follow-up.

Behavioral: Intervention group
Please see the preceding section

No Intervention: Control group

12 Family physicians in primary care will constitute the Control group. They will enroll 10 patients each from their ordinary practice. The physicians will not be provided with any information of the treatment model of the study but they will have all information about how to collect and register data. The patients on this group will also sign consent to provide data and therefore they will know about the study but they do not get any specific information about weight loss other than the general information that their physician may tell them. The patients in the Control Group will be asked to give data on inclusion visit and again 12 months later, and also at 6 and 12 months thereafter (i.e. 0, 12, 18 and 24 months from inclusion).

Outcome Measures

Primary Outcome Measures

  1. Weight reduction [12 months]

    10% weight reduction measured as kilo weight at inclusion

Secondary Outcome Measures

  1. Blood pressure [12 months]

    Blood pressure measured as mean of three measurements at rest

  2. HbA1c [12 months]

    Blood samples

  3. Waist measure [12 months]

    Any reduction in cm of waist measure

  4. Total Cholesterol [12 months]

    Blood samples

Other Outcome Measures

  1. Qualitative study [24 months]

    Participating physicians and patients will be interviewed about their experiences With the intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 69 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • BMI _> 30 OR _25 With at least one Medical condition related to overweight (hypertension, dyslipidemia, metabolic syndrome, diabetes mellitus II, hip- or knee pain)

  • written consent

  • sufficient knowledge in Norwegian Language to acquire the written and oral information

Exclusion Criteria:
  • any ongoing cancer condition

  • any current medication impacting on weight

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Oslo

Investigators

  • Study Director: Jørund Straand, Prof., Ph.D, University of Oslo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Erik L Werner, Professor, University of Oslo
ClinicalTrials.gov Identifier:
NCT03000062
Other Study ID Numbers:
  • MDN01
First Posted:
Dec 21, 2016
Last Update Posted:
Jun 22, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Erik L Werner, Professor, University of Oslo
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 22, 2021